Levodopa

leucine rich repeat kinase 2 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33459660 Therapies for Genetic Forms of Parkinson's Disease: Systematic Literature Review. 2021 1
2 29369408 Exploring the functional impact of mutational drift in LRRK2 gene and identification of specific inhibitors for the treatment of Parkinson disease. 2018 Jun 1
3 28186666 Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients. 2017 May 2
4 27111571 The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot. 2016 Oct 1
5 27169991 LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias. 2016 May 11 2
6 25840672 Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene. 2015 May 1
7 22038903 LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation. 2012 Jan 1
8 22703868 Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. 2012 Nov 1
9 18258746 A Drosophila model for LRRK2-linked parkinsonism. 2008 Feb 19 1
10 17388990 A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. 2007 Apr 2
11 17427941 Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease. 2007 May 15 1
12 18379513 [A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population]. 2007 1
13 16172858 Lrrk2 pathogenic substitutions in Parkinson's disease. 2005 Dec 2